Best Drug Development Company

RNS Number : 8786J
Immupharma PLC
08 April 2010
 



For Immediate Release

8 April 2010

 

 

 

ImmuPharma PLC

 

("ImmuPharma")

 

ImmuPharma awarded Best Drug Development Company in Europe Award

 

ImmuPharma PLC (LSE: IMM) the specialist discovery and development pharmaceutical company, has been voted "Best Drug Development Company, Europe" at The New Economy Pharmaceutical & Healthcare Awards 2010.

 

This award follows on from two notable wins in 2009 namely; "Best Technology Award" at the AIM Awards, organized by the London Stock Exchange and "Breakthrough of the year 2009" at the European Mediscience Awards.

 

- Ends -

 

For further information please contact:

 

ImmuPharma PLC

+44 20 7152 4080

Dimitri Dimitriou, Chief Executive Officer

Richard Warr, Chairman




Buchanan Communications

+44 20 7466 5000

Lisa Baderoon

George Prassas




Panmure Gordon & Co                                                           

Andrew Burnett

Rakesh Sharma

+44 151 243 0963



Noble & Company Limited

+44 20 7763 2200

James Bromhead

 


 

Notes to Editors:

 

About ImmuPharma PLC

 

ImmuPharma is a drug discovery and development group with its key operations in London and subsidiaries in Mulhouse, France and Basle, Switzerland. The Company aims to develop novel drugs to treat serious medical conditions for which there is a high unmet need. It has five drugs in development to treat 1) Lupus, 2) Cancer, 3) Severe Pain, 4) Highly resistant infections like MRSA and 5) Inflammatory and Allergic disorders.

 

Its lead candidate for the treatment of Lupus, LupuzorTM, a chronic, life-threatening autoimmune disease, was licensed to Cephalon, Inc in a transaction worth up to $500m in milestone payments in addition to significant royalties.  $45m in cash has been received to date.

 

The company also has a strong proprietary and collaborative drug development pipeline.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPLPEALEEEF

Companies

Immupharma (IMM)
UK 100

Latest directors dealings